Judge Blocks VA Dems' Insane Congressional Map
The Democrats' New Plan for the Midterms Is Crazy
Abigail Spanberger's Raising Taxes, So Boeing Is Fleeing Virginia
NC Police Confirm Republican Candidate Was Target of Drive-By Shooting
Lawyer for Illegal Immigrant Who Killed GA Teacher Wants Bond. Here's the Maddening...
Ohio Bill Offers Real Solution to Suicides by Gun
Tucker Carlson Claims He Was Detained and Interrogated in Israel, but That's Not...
Chinese National Convicted in $2.2M Gift Card Scheme
Stolen Ambulance Rammed into DHS Building in Utah
Leftist Policies Might Drive Chicago Bears to Indiana
Trump Gives Iran 10–15 Days to Strike Deal or Face ‘Unfortunate’ Consequences
Trump Gives Strongest Backing Yet to Georgia's Mike Collins
Former Corsa Coal VP Convicted in $140M Egyptian Bribery Scheme
Optum Director Convicted for Ghost Employee Kickbacks Over $1.2M
Nigerian National Extradited, Sentenced to 8 Years in Attempted $8M Tax Refund Scheme
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’
AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos